BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/19/2016 9:45:00 AM | Browse: 987 | Download: 1986
 |
Received |
|
2016-01-21 14:15 |
|
Peer-Review Started |
|
2016-01-21 17:49 |
|
To Make the First Decision |
|
2016-02-18 11:47 |
|
Return for Revision |
|
2016-02-19 13:46 |
|
Revised |
|
2016-03-01 15:31 |
|
Second Decision |
|
2016-03-04 18:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2016-03-14 10:26 |
|
Articles in Press |
|
2016-03-14 10:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2016-03-18 08:49 |
|
Typeset the Manuscript |
|
2016-04-07 09:08 |
|
Publish the Manuscript Online |
|
2016-04-19 09:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qian-Qian Yu, Hong Qiu, Ming-Sheng Zhang, Guang-Yuan Hu, Bo Liu, Liu Huang, Xin Liao, Qian-Xia Li, Zhi-Huan Li and Xiang-Lin Yuan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81372664 |
|
| Corresponding Author |
Xiang-lin Yuan, PhD, MD, Professor of Medicine, Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei Province, China. yxl@medmail.com.cn
|
| Key Words |
Bilirubin; Irinotecan; Metastatic colorectal cancer; Response; UGT1A1*28 |
| Core Tip |
Serum bilirubin was reported to be associated with irinotecan-induced toxicity. The current study evaluated whether baseline bilirubin levels could predict treatment response of metastatic colorectal cancer patients given irinotecan-based chemotherapy in a Chinese population and found that a lower bilirubin level was an independent predictor of irinotecan treatment response.
|
| Publish Date |
2016-04-19 09:42 |
| Citation |
Yu QQ, Qiu H, Zhang MS, Hu GY, Liu B, Huang L, Liao X, Li QX, Li ZH, Yuan XL. Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy. World J Gastroenterol 2016; 22(16): 4250-4258 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i16/4250.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i16.4250 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
